BTG International Ltd (2009) Structured phospholipids. US2009/0036410 A1.

Full text not available from this repository.

Abstract

A method of treating a patient in need of therapy for a disease in which cyokines have become dysregulated, or are otherwise capable of modulation to provide therapeutic benefit, is provided comprising administering to that patient a therapeutically effective dose of a phospholipid comprising a phosphatidyl group esterifed with one or more fatty acyl groups, characterised in that the phospholipid has at least one fatty acyl group at the sn-1 and/or sn-2 position of the phosphatidyl group, the fatty acyl group being selected from the group consisting of .gamma.-linolenoyl, dihomo-.gamma.-linolenoyl acid and arachidonoyl.

Item Type:	Patent
Uncontrolled Keywords:	structured phospholipids, cytokines, multiple sclerosis
Subjects:	R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/4325

Actions (login required)

View Item